Literature DB >> 24998278

Predictive Performance of SYNTAX Score II in Patients With Left Main and Multivessel Coronary Artery Disease-analysis of CREDO-Kyoto registry.

Carlos M Campos1, David van Klaveren, Javaid Iqbal, Yoshinobu Onuma, Yao-Jun Zhang, Hector M Garcia-Garcia, Marie-Angele Morel, Vasim Farooq, Hiroki Shiomi, Yutaka Furukawa, Yoshihisa Nakagawa, Kazushige Kadota, Pedro A Lemos, Takeshi Kimura, Ewout W Steyerberg, Patrick W Serruys.   

Abstract

BACKGROUND: SYNTAX score II (SSII) provides individualized estimates of 4-year mortality after coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in order to facilitate decision-making between these revascularization methods. The purpose of the present study was to assess SSII in a real-world multicenter registry with distinct regional and epidemiological characteristics. METHODS AND
RESULTS: Long-term mortality was analyzed in 3,896 patients undergoing PCI (n=2,190) or CABG (n=1,796) from the Coronary REvascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) PCI/CABG registry cohort-2. SSII discriminated well in both CABG and PCI patient groups (concordance index [c-index], 0.70; 95% CI: 0.68-0.72; and 0.75, 95% CI: 0.72-0.78) surpassing anatomical SYNTAX score (SS; c-index, 0.50; 95% CI: 0.47-0.53; and 0.59, 95% CI: 0.57-0.61). SSII had the best discriminative ability to separate low-, medium- and high-risk tertiles, and calibration plots showed good predictive performance for CABG and PCI groups. Use of anatomical SS as a reference improved the overall reclassification provided by SSII, with a net reclassification index of 0.5 (P<0.01).
CONCLUSIONS: SSII has robust prognostic accuracy, both in CABG and in PCI patient groups and, compared with the anatomical SS alone, was more accurate in stratifying patients for late mortality in a real-world complex coronary artery disease Eastern population.

Entities:  

Mesh:

Year:  2014        PMID: 24998278     DOI: 10.1253/circj.cj-14-0204

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  14 in total

1.  Unprotected Left Main Disease: Indications and Optimal Strategies for Percutaneous Intervention.

Authors:  Jun Li; Sandeep M Patel; Manish A Parikh; Sahil A Parikh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-03

2.  Comparison of the Predictive Roles of Risk Scores of In-Hospital Major Adverse Cardiovascular Events in Patients with Non-ST Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

Authors:  Erdal Aktürk; Lütfü Aşkın; Hakan Taşolar; Serdar Türkmen; Hakan Kaya
Journal:  Med Princ Pract       Date:  2018-04-19       Impact factor: 1.927

3.  A new concordance measure for risk prediction models in external validation settings.

Authors:  David van Klaveren; Mithat Gönen; Ewout W Steyerberg; Yvonne Vergouwe
Journal:  Stat Med       Date:  2016-06-01       Impact factor: 2.373

4.  Balancing idealism with realism to safeguard the welfare of patients: The importance of Heart Team led decision-making in patients with complex coronary artery disease.

Authors:  Vasim Farooq; Carlo Di Mario; Patrick W Serruys
Journal:  Indian Heart J       Date:  2016-01-12

5.  Predictive value of SYNTAX score II for clinical outcomes in octogenarian undergoing percutaneous coronary intervention.

Authors:  Evan Kurniawan; Feng-Hua Ding; Qi Zhang; Zhen-Kun Yang; Jian Hu; Wei-Feng Shen; Rui-Yan Zhang
Journal:  J Geriatr Cardiol       Date:  2016-09       Impact factor: 3.327

6.  Usefulness of SYNTAX score II in complex percutaneous coronary interventions in the setting of acute coronary syndrome.

Authors:  Azzarelli Salvatore; Marouane Boukhris; Simona Giubilato; Salvatore Davide Tomasello; Marine Castaing; Rocco Giunta; Francesco Marzà; Hosam Mohamad Abdelbasset; Hazem Khamis; Alfredo Ruggero Galassi
Journal:  J Saudi Heart Assoc       Date:  2015-07-28

7.  The Association between Monocyte HDL-C Ratio and SYNTAX Score and SYNTAX Score II in STEMI Patients Treated with Primary PCI.

Authors:  Metin Çağdaş; Süleyman Karakoyun; Mahmut Yesin; İbrahim Rencüzoğulları; Yavuz Karabağ; Mahmut Uluganyan; Mustafa Ozan Gürsoy; İnanç Artaç; Doğan İliş; Eray Atalay; Öznur Sadioğlu Çağdaş
Journal:  Acta Cardiol Sin       Date:  2018-01       Impact factor: 2.672

8.  Predictive Ability of the SYNergy Between Percutaneous Coronary Intervention with TAXus and Cardiac Surgery Score II for Long-term Mortality in Patients with Three-vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Treated with Second-generation Drug-eluting Stents.

Authors:  Ji-Qiang He; Xian-Peng Yu; Cheng Peng; Quan Li; Ya-Wei Luo; Yue-Chun Gao; Xiao-Ling Zhang; Chang-Yan Wu; Hua Zhao; Yu-Chen Zhang; Jing-Hua Liu; Shu-Zheng Lyu; Fang Chen
Journal:  Chin Med J (Engl)       Date:  2015-08-20       Impact factor: 2.628

9.  SYNTAX score II predicts long-term mortality in patients with one- or two-vessel disease.

Authors:  Maxime M Vroegindewey; Anne-Sophie Schuurman; Rohit M Oemrawsingh; Robert-Jan van Geuns; Isabella Kardys; Jurgen Ligthart; Joost Daemen; Eric Boersma; Patrick W Serruys; K Martijn Akkerhuis
Journal:  PLoS One       Date:  2018-07-02       Impact factor: 3.240

10.  Prognostic Value of SYNTAX Score II in Patients with Acute Coronary Syndromes Referred for Invasive Management: A Subanalysis from the SPUM and COMFORTABLE AMI Cohorts.

Authors:  Slayman Obeid; Antonio H Frangieh; Lorenz Räber; Nooraldaem Yousif; Thomas Gilhofer; Kyohei Yamaji; Milosz Jaguszewski; Soheila Aghlmandi; James Adams; Yannik Bockhorn; Christian Templin; Barbara E Stähli; Peter Jüni; Nicolas Rodondi; François Mach; Marco Roffi; Stephan Windecker; Willibald Maier; Fabian Nietlispach; Christian M Matter; Roland Klingenberg; Thomas F Lüscher
Journal:  Cardiol Res Pract       Date:  2018-09-25       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.